chr6-149749881-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001252049.1(PCMT1):āc.154C>Gā(p.Leu52Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000747 in 1,605,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/15 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001252049.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCMT1 | NM_001360452.2 | c.-21C>G | 5_prime_UTR_variant | 1/8 | ENST00000464889.7 | NP_001347381.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCMT1 | ENST00000464889.7 | c.-21C>G | 5_prime_UTR_variant | 1/8 | 1 | NM_001360452.2 | ENSP00000420813.2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000430 AC: 1AN: 232324Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 126224
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1453312Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 722164
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152358Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2024 | The c.154C>G (p.L52V) alteration is located in exon 1 (coding exon 1) of the PCMT1 gene. This alteration results from a C to G substitution at nucleotide position 154, causing the leucine (L) at amino acid position 52 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at